Frontiers in Immunology (Jun 2021)

Hemadsorption as a Treatment Option for Multisystem Inflammatory Syndrome in Children Associated With COVID-19. A Case Report

  • Juan Carlos Ruiz-Rodríguez,
  • Juan Carlos Ruiz-Rodríguez,
  • Luis Chiscano-Camón,
  • Luis Chiscano-Camón,
  • Clara Palmada,
  • Clara Palmada,
  • Adolf Ruiz-Sanmartin,
  • Adolf Ruiz-Sanmartin,
  • Marina García-de-Acilu,
  • Marina García-de-Acilu,
  • Erika Plata-Menchaca,
  • Erika Plata-Menchaca,
  • Janire Perurena-Prieto,
  • Janire Perurena-Prieto,
  • Manuel Hernandez-Gonzalez,
  • Manuel Hernandez-Gonzalez,
  • Marcos Pérez-Carrasco,
  • Marcos Pérez-Carrasco,
  • Pere Soler-Palacin,
  • Ricard Ferrer,
  • Ricard Ferrer

DOI
https://doi.org/10.3389/fimmu.2021.665824
Journal volume & issue
Vol. 12

Abstract

Read online

Multisystem Inflammatory Syndrome in Children (MIS-C) associated with COVID-19 is characterized by hypercytokinemia leading to overwhelming inflammation. We describe the use of a hemadsorption device as part of the supportive treatment for cytokine storm.

Keywords